A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 Diabetes

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorHaisco Pharmaceutical Group Co., Ltd.

About this trial

This study will compare the effect and safety of cofrogliptin (HSK7653) with acarbose among people with type 2 diabetes

1.Capable of understanding and voluntarily signing the written informed consent form.

1.Known hypersensitivity to any component of the investigational product, chemically related compounds, or excipients.

200 Participants

are divided into 2 treatment groups

Haisco Pharmaceutical Group Co., Ltd.

Lead sponsor